EHP Funds Inc. Takes Position in Cencora, Inc. $COR

EHP Funds Inc. bought a new position in shares of Cencora, Inc. (NYSE:COR) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,600 shares of the company’s stock, valued at approximately $500,000.

Other hedge funds have also recently modified their holdings of the company. Pathstone Holdings LLC lifted its stake in Cencora by 1.6% in the 3rd quarter. Pathstone Holdings LLC now owns 50,196 shares of the company’s stock valued at $15,688,000 after buying an additional 813 shares in the last quarter. Boston Partners increased its stake in Cencora by 2.0% during the 3rd quarter. Boston Partners now owns 4,509,165 shares of the company’s stock worth $1,409,152,000 after buying an additional 89,506 shares in the last quarter. Eisler Capital Management Ltd. acquired a new position in shares of Cencora during the third quarter valued at approximately $299,000. Kentucky Retirement Systems Insurance Trust Fund raised its holdings in shares of Cencora by 2.3% during the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 4,819 shares of the company’s stock valued at $1,506,000 after acquiring an additional 108 shares during the last quarter. Finally, Marshall Wace LLP lifted its position in shares of Cencora by 518.9% in the third quarter. Marshall Wace LLP now owns 1,995,118 shares of the company’s stock valued at $623,534,000 after acquiring an additional 1,672,762 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Robert W. Baird set a $415.00 price target on Cencora in a research note on Tuesday, January 13th. Barclays increased their price objective on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research note on Thursday, February 5th. Wells Fargo & Company upped their target price on shares of Cencora from $405.00 to $429.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Finally, Wall Street Zen cut shares of Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Cencora currently has an average rating of “Moderate Buy” and a consensus target price of $399.00.

Cencora Price Performance

COR stock opened at $349.69 on Friday. Cencora, Inc. has a 1 year low of $252.49 and a 1 year high of $377.54. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. The firm has a market capitalization of $68.03 billion, a PE ratio of 42.03, a price-to-earnings-growth ratio of 1.64 and a beta of 0.68. The business has a 50 day simple moving average of $355.58 and a 200-day simple moving average of $338.13.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the business posted $3.73 earnings per share. Equities research analysts anticipate that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. Cencora’s payout ratio is presently 28.85%.

Insider Activity

In other Cencora news, EVP Elizabeth S. Campbell sold 3,351 shares of Cencora stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the transaction, the executive vice president directly owned 23,891 shares of the company’s stock, valued at $8,173,111.10. The trade was a 12.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Silvana Battaglia sold 1,677 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $345.00, for a total transaction of $578,565.00. Following the completion of the transaction, the executive vice president owned 18,796 shares in the company, valued at $6,484,620. The trade was a 8.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 15,220 shares of company stock valued at $5,282,867. 0.38% of the stock is currently owned by insiders.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.